| 20/10/2023 |
Note |
Inclusion of Morocco on the list of countries at risk of WNV infection for human body products donation |
| 05/10/2023 |
Note |
Biological test in case of cured syphilis in candidates for blood donation |
| 31/08/2023 |
Avis |
Opinion regarding the risk of contamination with Strongyloides stercoralis following transplantation of human body products |
| 07/08/2023 |
Note |
Tick-borne encephalitis virus (TBEV) – Update of the French High Council for Public Health opinion of July 23, 2020 |
| 11/07/2023 |
Avis |
Referral related to systematic screening for cytomegalovirus in gamete and embryo donors |
| 06/07/2023 |
Avis |
Update of the HCSP opinions issued during the Covid-19 health crisis concerning the management of healthcare waste |
| 22/06/2023 |
Avis |
Timeliness of a vaccination campaign in Mayotte (shortage of drinking water) |
| 16/06/2023 |
Avis |
Funeral risks and respiratory viruses |
| 01/06/2023 |
Avis |
New recommendations for sorting healthcare waste in connection with the revision of the national guide on the elimination of waste from healthcare activities |
| 20/04/2023 |
Avis |
Referral related to prevention measures to be taken due to the risk of transmission of hepatitis E virus (HEV) from donors of products or elements of the human body |
| 06/04/2023 |
Avis |
Opinion on the drafting of the National Food, Nutrition and Climate Strategy (SNANC) |
| 28/03/2023 |
Avis |
Securing human body products in anticipation of the circulation of the West-Nile virus in metropolitan France |
| 13/01/2023 |
Avis |
Statement on measures of security for human body products owing to a human case report of West Nile virus (WNV) infection in mainland France outside the seasonal alert period |
| 30/12/2022 |
Avis |
Update of the opinions on the safety of human body products in the fields of transplantation and MPA with regard to Covid-19 |
| 16/12/2022 |
Avis |
Notice on the mandatory reporting of leptospirosis |
| 21/10/2022 |
Avis |
Treatment of sewage sludge in relation to the risk of SARS-CoV-2 infection |
| 19/10/2022 |
Avis |
Securing human body products in the context of the occurrence of autochthonous dengue cases in the south of France |
| 29/07/2022 |
Avis |
Canine olfactory screening in the screening strategy of SARS-CoV-2 infection |
| 08/07/2022 |
Avis |
Preventive measures against Monkeypox virus infection |
| 21/06/2022 |
Avis |
Statement on the coverage of vitamin D and iron requirements of the general population |
| 09/06/2022 |
Avis |
Prevention of monkeypox virus transmission through labile blood products, grafts and other human body products and components |
| 09/06/2022 |
Avis |
What to do for people at risk of severe Monkeypox virus infection |
| 24/05/2022 |
Avis |
What to do after the occurrence of a suspected, probable or confirmed case of Monkeypox virus infection |
| 28/04/2022 |
Avis |
Implementation of preventive measures against the transmission of the Ebola virus through human body products and parts |
| 28/04/2022 |
Avis |
Measures to prevent the risks associated with the Zika virus and the dengue virus in the field of medically assisted procreation (MPA) |
| 22/04/2022 |
Avis |
Health impacts of the possible use of non-conventional water as a substitute for water intended for human consumption |
| 19/04/2022 |
Avis |
Sedentary lifestyles and physical activity in the aftermath of a health crisis |
| 15/04/2022 |
Avis |
Number of masks, respirators and other personal protective equipment to be kept in State stock |
| 11/04/2022 |
Avis |
Use of Evusheld® for pre-exposure prophylaxis of Covid-19 |
| 01/04/2022 |
Avis |
Prevention of invasive infections in patients treated with complement inhibitors |
| 23/03/2022 |
Avis |
Public health issues and health Rendezvous for migrants from conflict zones in Ukraine |
| 18/03/2022 |
Avis |
Management of health risks related to pesticides and pesticide metabolites in water intended for human consumption |
| 03/03/2022 |
Avis |
Barrier measures and tuberculosis: definition of contacts and case investigation |
| 11/02/2022 |
Avis |
Evolution of the doctrine of testing and isolation of cases and contacts in the context of the declining spread of the Omicron variant of Sars-CoV-2 |
| 11/02/2022 |
Avis |
Update of selection criteria for donors of labile blood products and tissues in the context of a Covid-19 pandemic with a predominant circulation of the Omicron variant of SARS-CoV-2 |
| 27/01/2022 |
Synthèse |
Avis relatif aux usages et bon usage de la mesure de la santé perçue et de la qualité de vie en France |
| 21/01/2022 |
Avis |
Notice relating to the measurement of carbon dioxide in the indoor air of establishments open to the public |
| 18/01/2022 |
Avis |
Revision of the dietary guidelines for pregnant and breastfeeding women |
| 07/01/2022 |
Avis |
FFP2 respiratory protective devices for health professionals in the context of the fight against the spread of the SARS-CoV-2 virus in relation to the emergence of the Omicron variant (supplement) |
| 23/12/2021 |
Avis |
FFP2 respiratory protective devices in the general population to fight against the spread of the SARS-CoV-2 virus in relation to the emergence of the Omicron variant |
| 10/12/2021 |
Avis |
Statement on the prevention of the transmission of swine and avian influenza viruses to humans |
| 26/11/2021 |
Avis |
Report on the benefits and risks of electronic cigarettes |
| 26/11/2021 |
Avis |
Report on the benefits and risks of electronic cigarettes |
| 20/10/2021 |
Avis |
Management of patients with suspected viral haemorrhagic fever, including Ebola virus disease |
| 08/10/2021 |
Avis |
Evaluation of the future 2022-2025 infection and antibiotic resistance prevention strategy |
| 06/08/2021 |
Avis |
Strategy for the State’s stock of masks and personal protective equipment |
| 22/07/2021 |
Avis |
Measures to prevent the risks associated with the SARS-CoV-2 virus in the field of medically-assisted procreation |
| 06/07/2021 |
Avis |
Protection of the population with stable iodine in the event of a nuclear accident |
| 05/07/2021 |
Avis |
Statement concerning the management of new situations of exposure to extreme heatwaves - general recommendations |
| 18/06/2021 |
Avis |
Covid-19: contact tracing and barrier measures for fully vaccinated persons |
| 17/06/2021 |
Avis |
Covid-19: IL1 and IL6 antagonist treatment recommendations |
| 16/06/2021 |
Avis |
List of countries at risk of West Nile virus (WNV) transmission for donations of human body products |
| 11/06/2021 |
Avis |
Hantavirus infections and risks for donations of human body products |
| 16/05/2021 |
Avis |
Covid-19: persistent symptoms post Covid-19 |
| 11/05/2021 |
Avis |
Occupational activity of persons at risk of severe Covid-19 who have received a full vaccination schedule |
| 03/05/2021 |
Avis |
Safety of organ, tissue and cell donations from donors who have been vaccinated for less than one month with an anti-SARS-CoV-2 vaccine |
| 03/05/2021 |
Avis |
Securing donations of human body products against dengue fever in the French West Indies, Reunion Island and Metropolitan France |
| 28/04/2021 |
Avis |
Covid-19 : aeration, ventilation and CO2 measurement in Public Accesses Buildings (PAB) |
| 23/04/2021 |
Avis |
Covid-19 : Incineration of waste from care activities with infectious risks (WFIW) and rationalisation of WFIW |
| 18/04/2021 |
Avis |
Covid-19: strategy for defining measures to allow the reopening of Public Accesses Buildings (PAB) |
| 16/04/2021 |
Avis |
Health recommendations 2021 for travellers (for the attention of health professionals) |
| 15/04/2021 |
Avis |
Cell, tissue and organ donor selection in response to new SARS-CoV-2 variants |
| 02/04/2021 |
Avis |
Covid-19: adaptation of isolation recommendations for professionals in health care institutions or social and medico-social establishments (EMS) |
| 23/03/2021 |
Avis |
Covid-19: treatment guidelines: tocilizumab and monoclonal antibodies (updated 23/03/2021) |
| 09/03/2021 |
Avis |
Cell, Tissue and Organ Donor Selection in the Context of Pandemic Covid-19 |
| 02/03/2021 |
Avis |
Covid-19: Organization of prevention in nursing homes (NHs) and in long term care facilities (LTCFs) |
| 01/03/2021 |
Avis |
Covid-19: Prioritization of iterative salivary tests |
| 03/02/2021 |
Avis |
Covid-19: Monitoring and preventing the spread of new virus variants in health care settings |
| 02/02/2021 |
Avis |
Deferral criteria for donors with Covid-19 vaccination |
| 28/01/2021 |
Avis |
Recommendations for the sterilization of baby bottles in health care facilities |
| 28/01/2021 |
Avis |
Covid-19: treatment recommendations (updated 28/01/2021) |
| 28/01/2021 |
Rapport |
Controlling the risk associated with lead in the outdoor environment |
| 20/01/2021 |
Avis |
Covid-19: monitoring the spread of new virus variants (supplement) |
| 14/01/2021 |
Avis |
Covid-19: monitoring the spread of new virus variants |
| 17/12/2020 |
Avis |
Covid-19: Delay in patient’s transfer to a follow-up care service or a nursing home (NH) (additional guidelines) |
| 15/12/2020 |
Avis |
Risks of tattooing and tattoo removal products and practices |
| 09/12/2020 |
Avis |
Covid-19: Sanitary conditions for the end-of-year celebrations 2020 |
| 28/11/2020 |
Avis |
Notice concerning the updating of prevention measures against the dengue virus to be applied to products derived from the human body in the Fren |
| 22/11/2020 |
Avis |
Covid-19: Evaluation of a strengthened health protocol for shops |
| 13/11/2020 |
Avis |
Prophylaxis of invasive meningococcal disease in patients treated with ravulizumab and eculizumab |
| 06/11/2020 |
Avis |
Transfusion and transplant safety following indigenous dengue cases |
| 29/10/2020 |
Avis |
Covid-19: update of the list of risk factors for severe forms |
| 29/10/2020 |
Avis |
Masks in the fight against the spread of SARS-CoV-2 |
| 24/10/2020 |
Avis |
SARS-CoV-2: Cell, tissue and organ donors |
| 23/10/2020 |
Avis |
Covid-19: transfer delay of Covid-19 patients towards follow-up care service or a retirement home |
| 20/10/2020 |
Avis |
Coronavirus SARS-CoV-2: recommendations on barrier measures for physical activity and sport |
| 19/10/2020 |
Avis |
Use of dexamethasone and other corticosteroids in Covid-19 |
| 14/10/2020 |
Avis |
French Guidelines on the Use of Heaters during the Covid-19 Epidemic |
| 14/10/2020 |
Avis |
French Guidelines on the Use of Heaters during the Covid-19 Epidemic |
| 11/10/2020 |
Avis |
Covid-19 screening strategies in health and medico-social establishments |
| 06/10/2020 |
Avis |
Covid-19 : pregnant women and work |
| 25/09/2020 |
Avis |
What to do following the discovery of animal tuberculosis with Mycobacterium bovis? |
| 25/09/2020 |
Avis |
Notice on post-exposure treatment of rabies |
| 17/09/2020 |
Avis |
Covid-19: co-circulation of SARS-CoV-2 and winter viruses |
| 17/09/2020 |
Avis |
Covid-19: Complementary recommendations on strategies to prevent the spread of SARS-CoV-2 in child care and school settings |
| 17/09/2020 |
Rapport |
Statement and report on the in itinere evaluation of the National Public Health Plan |
| 09/09/2020 |
Avis |
Covid-19: recommendations on masks within child care settings |
| 28/08/2020 |
Avis |
Collective enclosed spaces and Covid-19: mask wearing and possible adaptations at the workplace |
| 23/08/2020 |
Avis |
Sports and cultural events: wearing masks to prevent Covid-19 |
| 20/08/2020 |
Avis |
Covid-19: recommendations for masks in enclosed public spaces |
| 11/08/2020 |
Avis |
Covid-19: oropharyngeal swabs and pooling |
| 23/07/2020 |
Avis |
SARS-CoV-2: Updates on aerosol transmission of the virus |
| 23/07/2020 |
Avis |
Covid-19: people at risk of developing severe forms of the disease |
| 25/06/2020 |
Avis |
Covid-19: Remdesivir (updated on 31 May 2020) |
| 22/06/2020 |
Avis |
Phase 3 containment lifting for companies |
| 18/06/2020 |
Avis |
Managing the Covid-19 epidemic and social inequalities in children’s health, lessons for the future |
| 09/05/2020 |
Avis |
Notice concerning the link between smoking and Covid-19 |
| 06/05/2020 |
Avis |
Statement on management of the Covid-19 epidemic in the event of the population’s exposure to heatwaves |
| 06/05/2020 |
Avis |
Coronavirus SARS-CoV-2: managing the epidemic in the event of heat waves |
| 06/05/2020 |
Avis |
Coronavirus SARS-CoV-2: recommendations relating to textiles, and to footwear and clothing retail outlets |
| 05/05/2020 |
Avis |
The Covid-19 epidemic: lifting the lockdown for individuals with disabilities |
| 01/05/2020 |
Avis |
Covid-19: bathing water and the use of water from the natural environment |
| 29/04/2020 |
Avis |
Coronavirus SARS-CoV-2: risks linked to the reuse and prolonged wearing of single-use face masks |
| 28/04/2020 |
Avis |
Temperature-taking to control access within the context of the Covid-19 epidemic |
| 24/04/2020 |
Avis |
Coronavirus SARS-CoV-2: Barrier and physical distancing measures for the general population |
| 08/04/2020 |
Avis |
Statement on the management at home or in a care facility of suspected or confirmed Covid-19 patients (supplementing the statements dated 5 and |
| 08/04/2020 |
Avis |
Statement on the management of waste containing adult incontinence products used by possible, probable and confirmed Covid-19 patients |
| 04/04/2020 |
Avis |
Statement on the opportunity for specific cleaning or disinfection of the pavements and public spaces |
| 01/04/2020 |
Synthèse |
Elaboration of a tool to characterize a housing in regard with health “Domiscore” Executive summary |
| 31/03/2020 |
Avis |
Statement on prevention and management of patients at risk of severe forms of Covid-19 and on priority access to diagnostic tests |
| 31/03/2020 |
Avis |
Statement on the protection of waste collection workers during the Covid-19 epidemic |
| 30/03/2020 |
Avis |
Statement on support for disabled people during the Covid-19 epidemic and the extended confinement period |
| 30/03/2020 |
Avis |
Coronavirus SARS-CoV-2: caring for people living in precarious circumstances |
| 24/03/2020 |
Avis |
SARS coronavirus-2: safe handling of bodies of deceased persons with suspected or confirmed Covid-19 |
| 23/03/2020 |
Avis |
SARS-CoV-2: therapeutic recommendations |
| 19/03/2020 |
Avis |
Management of clinical waste generated during the COVID-19 epidemic, particularly in the community |
| 17/03/2020 |
Avis |
Reducing the risk of SARS-CoV-2 transmission through ventilation and management of patients’ bodily fluids |
| 16/03/2020 |
Avis |
SARS coronavirus-2: clinical criteria for safely ending isolation of infected patients |
| 14/03/2020 |
Avis |
Provisional statement: Recommendations on prevention and management of Covid-19 in patients at risk of severe forms |
| 10/03/2020 |
Avis |
Provisional statement: Patients at risk of severe forms of Covid-19 and prioritising access to diagnostic tests |
| 05/03/2020 |
Avis |
Covid-19: management of confirmed cases |
| 24/02/2020 |
Avis |
Maintaining safe donations of blood, cells, tissue and organs while SARS-CoV-2 is actively circulating |
| 24/02/2020 |
Note |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 24/02/2020 |
Annexe |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 24/02/2020 |
Annexe |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 18/02/2020 |
Avis |
SARS coronavirus-2 (SARS-CoV-2): cleaning the premises of a confirmed patient and protecting staff |
| 14/06/2019 |
Avis |
On the measures for treating patients infected or colonised by Candida auris and on the benefit/risk ratio of prescribing prophylactic antifunga |
| 14/06/2019 |
Avis |
Dengue and Chikungunya: measures relating to the safety of blood transfusions and transplants |
| 23/05/2019 |
Avis |
West Nile: measures relating to the safety of blood transfusions and transplants |
| 02/05/2019 |
Synthèse |
Benchmarks for managing indoor air quality for formaldehyde |
| 02/05/2019 |
Rapport |
Benchmarks for managing indoor air quality for formaldehyde |
| 02/05/2019 |
Avis |
Benchmarks for managing indoor air quality for formaldehyde |
| 09/04/2019 |
Rapport |
Indications of non-pharmaceutical interventions to control the spread of transmissible infectious diseases |
| 22/03/2019 |
Avis |
Statement on 2019 health recommendations for travellers (for the attention of health professionals) |
| 28/02/2019 |
Avis |
Statement on the screening for urogenital schistosomiasis in populations visiting the rivers Cavu and Solenzara in south Corsica |
| 20/11/2018 |
Rapport |
Critical analysis of the draft National Strategy on Endocrine Disruptors 2 (SNPE2) and proposal of result indicators |
| 07/09/2018 |
Avis |
Management of clusters of invasive Kingella kingae infections in daycare facilities for children |
| 07/09/2018 |
Avis |
Indications for monoclonal antibody and antiviral treatment on a preventive and curative basis in health workers exposed to the Ebola virus |
| 22/06/2018 |
Avis |
Development of recommendations to authorize the release of irradiated sterile mosquitoes for the purposes of vector control |
| 22/06/2018 |
Avis |
Preventive measures via immunization against the Ebola virus of individuals likely to come into contact with patients at risk of transmission |
| 18/05/2018 |
Avis |
Use of primaquine as a radical treatment for P. vivax and P. ovale malaria in France |
| 18/05/2018 |
Avis |
Determination of an endemic threshold for tuberculosis |
| 18/05/2018 |
Avis |
Establishment of compulsory declaration of MERS-CoV infections |
| 17/05/2018 |
Rapport |
Evaluation of the 2013-2017 national patient safety programme |
| 29/04/2018 |
Rapport |
Protecting workers and persons living next to sites where titanium dioxide nanoparticles are produced or processed |
| 23/04/2018 |
Avis |
Statement on the management strategy through a major measles outbreak within France |
| 26/03/2018 |
Avis |
Statement on scientific and technical support relating to the recast of amended Directive 98/83/EC on the quality of water intended for human consumption |
| 16/03/2018 |
Avis |
Statement on the use of primaquine for altruistic purposes against Plasmodium falciparum malaria in Mayotte |
| 16/03/2018 |
Avis |
Prescription of antivirals in cases of seasonal influenza |
| 08/02/2018 |
Avis |
Statement on the assessment of the health strategy for persons placed under judicial control (PPJC |
| 22/12/2017 |
Rapport |
Prevention of Alzheimer’s disease and related diseases (ADRD) |
| 21/12/2017 |
Avis |
Statement on the medical care provided for and the monitoring of new-borns and infants having been exposed to the Zika virus in utero or present |
| 29/11/2017 |
Avis |
Statement on the referral dated 6 November 2017 on the draft for the French National Health Strategy |
| 13/10/2017 |
Avis |
Polioviruses and their potential introduction on lists of transmissible infections requiring or prohibiting certain funerary operations |
| 13/09/2017 |
Avis |
“Altruistic” use of Primaquine and Plasmodium falciparum malaria in French Guiana |
| 12/09/2017 |
Rapport |
For a public health nutrition policy in France. PNNS 2017-2021 |
| 08/09/2017 |
Rapport |
Statement on the National Health Strategy: Contribution of the French High Council for Public Health |
| 27/06/2017 |
Avis |
Information update on the risk of Borrelia transmission via labile blood products and grafts |
| 21/06/2017 |
Avis |
Medical certificate of no contraindication to the practice of sports for children, following Decree no.2016-1157 of 24 August 2016 |
| 23/05/2017 |
Avis |
Additional information regarding the measures to control the spread of emergent highly-resistant bacteria (eHRB) recommended in the opinion of the French HCPH of 27 September 2016 in view of the emergence of a plasmid mediated (mcr-1) colistin resistance in Enterobacteriaceae |
| 13/03/2017 |
Rapport |
Territorial Hospital Groups and public health |
| 16/02/2017 |
Avis |
Statement related to the revision of the 2017-2021 French Nutrition and Health Programme’s dietary guidelines for adults |
| 06/12/2016 |
Avis |
Microbiological diagnosis of carbapenemase-producing Enterobacteriaceae or colistin-resistant Enterobacteriaceae carrying the mcr-1 gene |
| 01/12/2016 |
Rapport |
Proposal of targets and indicators concerning the expected outcomes of the 3rd National Environmental Health Action Plan |
| 27/09/2016 |
Avis |
Measures to be taken with regard to the emergence of a plasmid-mediated resistance to (mcr-1) colistin in Enterobacteriaceae |
| 28/04/2016 |
Avis |
Information and recommendations to be issued with a view to preventing health risks associated with allergenic pollen |
| 22/02/2016 |
Avis |
Opinion concerning the risks and benefits in the use of electronic cigarettes by the general population |
| 25/06/2015 |
Avis |
On information regarding the nutritional quality of foodstuffs |
| 04/12/2014 |
Avis |
Management of health-care worker (HCW) in care settings who are victims of an AEB/AEV from a patient who is a confirmed index case of Ebola virus disease |
| 08/07/2014 |
Avis |
Booster vaccination against poliomyelitis for some travellers in the context of the current public health emergency declared by the WHO |
| 23/05/2014 |
Synthèse |
Lead exposure: determination of new risk management objectives |
| 25/04/2014 |
Avis |
Opinion concerning the risks and benefits in the use of electronic cigarettes by the general population |
| 15/11/2013 |
Avis |
Public health messages to be issued during episodes of pollution by particles, ozone, nitrogen dioxide and/or sulphur dioxide |
| 06/02/2013 |
Synthèse |
Indicators of "premature" and "avoidable" mortality |
| 19/01/2013 |
Synthèse |
Evaluation of the second national environmental health action plan - summary and recommendations |
| 21/12/2012 |
Avis |
Simplification of the French vaccination schedule |
| 13/04/2012 |
Synthèse |
Particulate matter in outdoor air pollution : Summary and recommendations for protecting health |
| 20/02/2012 |
Synthèse |
Mid-term evaluation of the 2009-2013 cancer plan |
| 07/12/2011 |
Avis |
Health policies in schools - Summary and recommendations for promoting students’ health |
| 02/12/2011 |
Avis |
Defining indications for the unavoidable use of sterile bottles and teats when feeding hospitalised infants and newborns |
| 18/11/2011 |
Avis |
Difficulties of producing solvent/detergent-treated plasma and on the arrangements for best meeting national therapeutic plasma needs |
| 21/10/2011 |
Synthèse |
Towards a global and integrated patient safety policy: Principles and recommendations |
| 14/06/2011 |
Synthèse |
Prevention of the healthcare worker-to-patient HBV, HCV, HIV transmission |
| 15/03/2011 |
Synthèse |
Evaluation of the National Program for improving pain management 2006 - 2010 |
| 04/02/2011 |
Synthèse |
Evaluation of the plan for preserving antibiotic efficacy 2007 - 2010 |
| 21/12/2010 |
Synthèse |
Évaluation des risques sanitaires dans les analyses de zone. Utilité, lignes méthodologiques et interprétation - Annexe 4 - International workshop synthesis english version |
| 21/12/2010 |
Rapport |
Health risk assessment in zone analyses. Utility, methodological issues and interpretation |
| 09/12/2010 |
Synthèse |
Assessment of the French National Plan on Healthy Ageing 2007-2009. Synthesis and recommendations |
| 02/02/2010 |
Rapport |
Recommendations relating to measures to be implemented to prevent the emergence of ESBL enterobacteriacae and fight against their spread
Proposals written up from the point of view of defining a national prevention programme |
| 12/11/2009 |
Synthèse |
Report on Therapeutic education within primary care - Synthesis and recommendations |
| 17/03/2009 |
Synthèse |
Assessment of National Rare Diseases Plan 2005-2008. Synthesis - April 2009 |
